Gary Larson

Gary Larson has extensive experience in the biopharmaceutical industry, with their most recent role being the Director of CMC Development Operations at Mosaic ImmunoEngineering Inc. Prior to this, they held various leadership positions at companies such as Xencor, Avid Bioservices, Peregrine Pharmaceuticals, Ardea Biosciences, and Valeant Pharmaceuticals. Throughout their career, Larson has been involved in activities such as protein characterization, analytical method development, QC lot release assays, and technical transfer of client assays.

Gary Larson attended UC Santa Barbara from 1998 to 2000, where they obtained a Bachelor of Science degree in Pharmacology.